Fibromyalgia Treatment Market, Global Outlook and Forecast 2023-2032
The global Fibromyalgia Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fibromyalgia syndrome (FS) is a non-articular rheumatic disorder characterized by pain and stiffness of the musculoskeletal system and tenderness in specific sites.Fibromyalgia syndrome can be secondary to trauma, a variety of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis and a variety of non-rheumatic diseases (such as hypothyroidism, malignant tumors).
This report aims to provide a comprehensive presentation of the global market for Fibromyalgia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibromyalgia Treatment. This report contains market size and forecasts of Fibromyalgia Treatment in global, including the following market information:
- Global Fibromyalgia Treatment Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Fibromyalgia Treatment Market Sales, 2018-2023, 2024-2032, (KG)
- Global top five Fibromyalgia Treatment companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antidepressants Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fibromyalgia Treatment include Eli Lilly and Company, Pfizer, Novartis AG, Allergan, Aptinyx, Prismic Pharmaceuticals, Innovative Med Concepts, Intec Pharma Ltd. and Astellas Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Fibromyalgia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fibromyalgia Treatment Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Fibromyalgia Treatment Market Segment Percentages, by Type, 2022 (%)
- Antidepressants
- Anticonvulsants
- Muscle Relaxants
- Narcotic Analgesics
- Non-narcotic Analgesics
Global Fibromyalgia Treatment Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Fibromyalgia Treatment Market Segment Percentages, by Application, 2022 (%)
- Hospitals Pharmacies
- Clinic Pharmacy
- Retail Drug Stores
- Online Pharmacies
Global Fibromyalgia Treatment Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (KG)
Global Fibromyalgia Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Fibromyalgia Treatment revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Fibromyalgia Treatment revenues share in global market, 2022 (%)
- Key companies Fibromyalgia Treatment sales in global market, 2018-2023 (Estimated), (KG)
- Key companies Fibromyalgia Treatment sales share in global market, 2022 (%)
key players include:
- Eli Lilly and Company
- Pfizer
- Novartis AG
- Allergan
- Aptinyx
- Prismic Pharmaceuticals
- Innovative Med Concepts
- Intec Pharma Ltd.
- Astellas Pharma
- Savella
- Sun Pharmaceutical Industries
- Mylan NV
- Teva Pharmaceutical Industries
- Daiichi Sankyo
- Forest Pharmaceuticals
- Meiji Seika Pharma
- Tonix Pharmaceuticals
- Theravance Biopharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fibromyalgia Treatment, market overview.
Chapter 2: Global Fibromyalgia Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Fibromyalgia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fibromyalgia Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fibromyalgia Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
